Exact Mass: 462.1022

Exact Mass Matches: 462.1022

Found 35 metabolites which its exact mass value is equals to given mass value 462.1022, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

farnesyl triphosphate

3,7,11-trimethyldodeca-2,6,10-trien-1-yl tetrahydrogen triphosphate

C15H29O10P3 (462.0974)


   

2-Ethoxy-3-[4-[2-[4-(trifluoromethylsulfonyloxy)phenyl]ethoxy]phenyl]propanoic acid

2-Ethoxy-3-[4-[2-[4-(trifluoromethylsulphonyloxy)phenyl]ethoxy]phenyl]propanoic acid

C20H21F3O7S (462.096)


   

Antibiotic DC 116

Antibiotic DC 116

C25H18O9 (462.0951)


   

inoscavin A

inoscavin A

C25H18O9 (462.0951)


   

emeguisin C

emeguisin C

C24H24Cl2O5 (462.1001)


   

C25H18O9

C25H18O9 (462.0951)


   

(+)-dalesconol A|dalesconol A|sporothrin A

(+)-dalesconol A|dalesconol A|sporothrin A

C29H18O6 (462.1103)


   

C24H24Cl2O5

C24H24Cl2O5 (462.1001)


   

emeguisin C

emeguisin C

C24H24O5Cl2 (462.1001)


   

di(propan-2-yl)-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)silane

di(propan-2-yl)-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)silane

C14H19F13Si (462.1048)


   

n-[(3-trimethoxysilyl)propyl]ethylenediamine triacetic acid trisodium salt

n-[(3-trimethoxysilyl)propyl]ethylenediamine triacetic acid trisodium salt

C14H25N2Na3O9Si (462.1022)


   

Eletriptan HBr

Eletriptan hydrobromide

C22H27BrN2O2S (462.0977)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist Eletriptan hydrobromide (Eletriptan HBr) is a selective 5-HT1B and 5-HT1D receptor agonist with Ki of 0.92 nM and 3.14 nM, respectively.

   

Acid Orange 156

Acid Orange 156

C21H19N4NaO5S (462.0974)


   

BMS-908662 free base

BMS-908662 free base

C24H19ClN4O4 (462.1095)


   

Rintodestrant

Rintodestrant

C26H19FO5S (462.0937)


C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2116 - Selective Estrogen Receptor Down Regulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist

   

7-(Methylthio)heptyl-glucosinolate

7-(Methylthio)heptyl-glucosinolate

C15H28NO9S3- (462.0926)


   

8-chloro-2-(2-phenylethyl)chromone-6-O-glucoside

8-chloro-2-(2-phenylethyl)chromone-6-O-glucoside

C23H23ClO8 (462.1081)


   

7-(3,4-Dihydroxyphenyl)-4-hydroxy-3-(4-hydroxy-3,5-dimethoxyphenyl)-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaen-11-one

7-(3,4-Dihydroxyphenyl)-4-hydroxy-3-(4-hydroxy-3,5-dimethoxyphenyl)-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaen-11-one

C25H18O9 (462.0951)


   

4-methoxy-N-[2-[(4-nitrophenyl)methylthio]-4-oxo-3-quinazolinyl]benzamide

4-methoxy-N-[2-[(4-nitrophenyl)methylthio]-4-oxo-3-quinazolinyl]benzamide

C23H18N4O5S (462.0998)


   

RLX-33

RLX-33

C24H19ClN4O4 (462.1095)


RLX-33 is a potent, selective and blood-brain barrier (BBB) penetrant relaxin family peptide 3 (RXFP3) antagonist, also blocks relaxin-3-induced ERK1/2 phosphorylation, with IC50 values of 2.36 μM for RXFP3, 7.82 and 13.86 μM for ERK1 and ERK2 phosphorylation, respectively. RLX-33 can block the stimulation of food intake induced by the RXFP3-selective agonist R3/I5 in rats. RLX-33 can be used for the research of metabolic syndrome[1].

   

4,12-bis(but-2-en-2-yl)-5,13-dichloro-14-hydroxy-6-methoxy-7,15-dimethyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one

4,12-bis(but-2-en-2-yl)-5,13-dichloro-14-hydroxy-6-methoxy-7,15-dimethyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one

C24H24Cl2O5 (462.1001)


   

2'-(3,4-dihydroxyphenyl)-6'-[2-(3,4-dihydroxyphenyl)ethenyl]-5-methyl-2'h-spiro[furan-2,3'-furo[3,2-c]pyran]-3,4'-dione

2'-(3,4-dihydroxyphenyl)-6'-[2-(3,4-dihydroxyphenyl)ethenyl]-5-methyl-2'h-spiro[furan-2,3'-furo[3,2-c]pyran]-3,4'-dione

C25H18O9 (462.0951)


   

{8,11-dihydroxy-2-[2-methyl-3-(prop-1-en-1-yl)oxiran-2-yl]-4,7,12-trioxo-1-oxatetraphen-5-yl}acetic acid

{8,11-dihydroxy-2-[2-methyl-3-(prop-1-en-1-yl)oxiran-2-yl]-4,7,12-trioxo-1-oxatetraphen-5-yl}acetic acid

C25H18O9 (462.0951)


   

3-[4,5-dihydroxy-2-(6-methyl-4-oxopyran-2-yl)phenyl]-6-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxypyran-2-one

3-[4,5-dihydroxy-2-(6-methyl-4-oxopyran-2-yl)phenyl]-6-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxypyran-2-one

C25H18O9 (462.0951)


   

(2r,11r)-7,15,26-trihydroxyheptacyclo[19.7.1.0²,¹¹.0²,²⁰.0³,⁸.0¹⁴,¹⁹.0²⁵,²⁹]nonacosa-1(29),3,5,7,14,16,18,20,22,25,27-undecaene-9,13,24-trione

(2r,11r)-7,15,26-trihydroxyheptacyclo[19.7.1.0²,¹¹.0²,²⁰.0³,⁸.0¹⁴,¹⁹.0²⁵,²⁹]nonacosa-1(29),3,5,7,14,16,18,20,22,25,27-undecaene-9,13,24-trione

C29H18O6 (462.1103)


   

4,6-dichloro-9-hydroxy-3,3,17-trimethyl-2,12-dioxapentacyclo[9.8.3.1¹⁰,¹⁴.0¹,⁶.0⁸,²¹]tricosa-8(21),9,11(22),14,17-pentaene-7,20-dione

4,6-dichloro-9-hydroxy-3,3,17-trimethyl-2,12-dioxapentacyclo[9.8.3.1¹⁰,¹⁴.0¹,⁶.0⁸,²¹]tricosa-8(21),9,11(22),14,17-pentaene-7,20-dione

C24H24Cl2O5 (462.1001)


   

(2s,11s)-7,15,26-trihydroxyheptacyclo[19.7.1.0²,¹¹.0²,²⁰.0³,⁸.0¹⁴,¹⁹.0²⁵,²⁹]nonacosa-1(29),3,5,7,14,16,18,20,22,25,27-undecaene-9,13,24-trione

(2s,11s)-7,15,26-trihydroxyheptacyclo[19.7.1.0²,¹¹.0²,²⁰.0³,⁸.0¹⁴,¹⁹.0²⁵,²⁹]nonacosa-1(29),3,5,7,14,16,18,20,22,25,27-undecaene-9,13,24-trione

C29H18O6 (462.1103)


   

(6ar,9r,9as)-9-acetyl-5-bromo-3-[(1e,3e,5s)-3,5-dimethylhepta-1,3-dien-1-yl]-6a-methyl-1h,9h,9ah,9bh-furo[2,3-h]isochromene-6,8-dione

(6ar,9r,9as)-9-acetyl-5-bromo-3-[(1e,3e,5s)-3,5-dimethylhepta-1,3-dien-1-yl]-6a-methyl-1h,9h,9ah,9bh-furo[2,3-h]isochromene-6,8-dione

C23H27BrO5 (462.1042)


   

(2s,2's)-2'-(3,4-dihydroxyphenyl)-6'-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-5-methyl-2'h-spiro[furan-2,3'-furo[3,2-c]pyran]-3,4'-dione

(2s,2's)-2'-(3,4-dihydroxyphenyl)-6'-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-5-methyl-2'h-spiro[furan-2,3'-furo[3,2-c]pyran]-3,4'-dione

C25H18O9 (462.0951)


   

4,12-bis[(2e)-but-2-en-2-yl]-5,13-dichloro-14-hydroxy-6-methoxy-7,15-dimethyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one

4,12-bis[(2e)-but-2-en-2-yl]-5,13-dichloro-14-hydroxy-6-methoxy-7,15-dimethyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one

C24H24Cl2O5 (462.1001)


   

7,15,26-trihydroxyheptacyclo[19.7.1.0²,¹¹.0²,²⁰.0³,⁸.0¹⁴,¹⁹.0²⁵,²⁹]nonacosa-1(29),3,5,7,14,16,18,20,22,25,27-undecaene-9,13,24-trione

7,15,26-trihydroxyheptacyclo[19.7.1.0²,¹¹.0²,²⁰.0³,⁸.0¹⁴,¹⁹.0²⁵,²⁹]nonacosa-1(29),3,5,7,14,16,18,20,22,25,27-undecaene-9,13,24-trione

C29H18O6 (462.1103)


   

{8,11-dihydroxy-2-[(2s,3s)-2-methyl-3-[(1z)-prop-1-en-1-yl]oxiran-2-yl]-4,7,12-trioxo-1-oxatetraphen-5-yl}acetic acid

{8,11-dihydroxy-2-[(2s,3s)-2-methyl-3-[(1z)-prop-1-en-1-yl]oxiran-2-yl]-4,7,12-trioxo-1-oxatetraphen-5-yl}acetic acid

C25H18O9 (462.0951)


   

7,14,22-trihydroxyheptacyclo[13.11.2.1²,⁶.0¹¹,²⁸.0¹⁸,²⁷.0²¹,²⁶.0¹⁰,²⁹]nonacosa-1,3,6,8,10(29),11(28),12,14,21,23,25-undecaene-5,16,20-trione

7,14,22-trihydroxyheptacyclo[13.11.2.1²,⁶.0¹¹,²⁸.0¹⁸,²⁷.0²¹,²⁶.0¹⁰,²⁹]nonacosa-1,3,6,8,10(29),11(28),12,14,21,23,25-undecaene-5,16,20-trione

C29H18O6 (462.1103)


   

(1s,4r,6r,14e,17e)-4,6-dichloro-9-hydroxy-3,3,17-trimethyl-2,12-dioxapentacyclo[9.8.3.1¹⁰,¹⁴.0¹,⁶.0⁸,²¹]tricosa-8(21),9,11(22),14,17-pentaene-7,20-dione

(1s,4r,6r,14e,17e)-4,6-dichloro-9-hydroxy-3,3,17-trimethyl-2,12-dioxapentacyclo[9.8.3.1¹⁰,¹⁴.0¹,⁶.0⁸,²¹]tricosa-8(21),9,11(22),14,17-pentaene-7,20-dione

C24H24Cl2O5 (462.1001)


   

3-[4,5-dihydroxy-2-(6-methyl-4-oxopyran-2-yl)phenyl]-6-[2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxypyran-2-one

3-[4,5-dihydroxy-2-(6-methyl-4-oxopyran-2-yl)phenyl]-6-[2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxypyran-2-one

C25H18O9 (462.0951)